The patient was diagnosed with ornithine transcarbamylase (OTC) deficiency (hyperammonemia type II), following an initial diagnosis of pervasive developmental disorder, selective mutism, and anorexia nervosa [43]. This evidence concerns the gene OTC and pervasive developmental disorder.